TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Annexon, Inc.
Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Annexon, a biopharmaceutical company, announced a public offering of 25,096,153 shares of common stock and pre-funded warrants, expecting to raise $75 million to support its neuroinflammation research platform.

Insights
ANNX   neutral

The company is raising capital through a public offering, which indicates a standard financial strategy for funding research and development without strong positive or negative implications